Stroke Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older (male or non-pregnant female) who are experiencing symptoms of an acute stroke.
- People who have a confirmed blockage in one of the major brain or neck arteries, identified through a CT scan, MRI scan, or specialised X-ray of the blood vessels.
- People who do not have a medical reason to avoid the type of dye (contrast) used in certain scans.
- People whose care team has already planned for them to receive a procedure to remove or unblock the clot in the blood vessel.
- People (or their legal representative) who have given their consent to take part in the study.
- People who are willing to attend follow-up appointments as required by the study.
Who may not be able to join:
- People whose stroke symptoms started more than 24 hours before their last known time of being well.
- People whose neurological symptoms are caused by something other than a blocked blood vessel, such as a brain bleed, bleeding around the brain, or a brain tumour.
- People who have other underlying conditions that affect calcium deposits in the arteries, such as an overactive thyroid, advanced kidney disease, long-term use of the blood thinner Warfarin, long-term vitamin D deficiency or excess, or persistently abnormal levels of magnesium, calcium, or phosphate in the blood, or high calcium intake through diet or supplements.
- People for whom a certain type of standard admission brain scan (non-contrast CT) is unavailable or has too much image interference to be read accurately.
- People with severely reduced kidney function, based on specific blood test measurements (confirm with trial site).
- People who have previously had a brain or blood vessel procedure, or brain surgery.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Duan Chuanzhi, MD, Zhujiang Hospital
Phone: +8613681134001
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of patients with a adverse functional outcome at 3 months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.